The team behind OdorSol
OdorSol wasn't born in a marketing meeting. It was invented by a practicing veterinarian and rigorously validated by a chemist whose career is dedicated to hypochlorous acid (HOCl) research. Every bottle is the product of decades of peer-reviewed science — not synthetic perfume.

The CEO
Joshua Johnston
MBA · Chief Executive Officer
Chief Executive Officer
The leader who turns vision into results.
Joshua Johnston is a business leader with experience building and scaling science-driven companies. He combines financial discipline, operational leadership, and commercial strategy to help innovative technologies become successful businesses.
A graduate of the University of Washington's Foster School of Business, Joshua has led ventures through fundraising, product launches, strategic partnerships, and commercial growth. Earlier in his career, he served in a senior finance role supporting an $80 million initial public offering on the London Stock Exchange, providing a foundation in capital markets, corporate finance, and organizational scale.
As Chief Executive Officer, Joshua leads the company's strategy, operations, and growth initiatives. He is responsible for aligning scientific innovation with commercial execution, building the partnerships, systems, and organizational capabilities required to bring trusted hypochlorous acid solutions to market and scale them successfully.
MBA
University of Washington · Foster School of Business
Capital Formation
IPOs, private placements & venture financing
Company Building
Governance, commercialization & organizational scale

The Inventor
Dr. Jeff Williams
DVM, PhD · Chief Science Officer
Chief Science Officer · Inventor
A veterinarian who spent 40 years proving that clean can be safe.
Dr. Jeff Williams began his career as a veterinary clinician in England, treating small animals before transitioning into academic biomedical research. He spent more than 25 years at Michigan State University, including two decades as Professor of Microbiology and Molecular Genetics. He still operates a working livestock farm in Washington state — caring for sheep and goats with the same products he formulates.
A globally recognized expert in microbiology and infectious diseases, Dr. Williams has authored over 200 scientific papers and textbook chapters. He is a Fellow of the American Association for the Advancement of Science (AAAS), has served on the Board of Counselors for the U.S. National Institute of Allergy and Infectious Diseases (NIH), and has been a trusted consultant to the World Health Organization in Geneva.
In 1998 he founded HaloSource Inc., a biotechnology company focused on advanced antimicrobial solutions. Today, as Chief Science Officer of OdorSol, he brings a rare combination of scientific rigor, hands-on veterinary experience, and global health perspective to every bottle.
B.V.Sc.
University of Bristol
Ph.D. Pathobiology
U. Penn · Fulbright Scholar
200+ Publications
Peer-reviewed science
WHO Consultant
Geneva · Argentina · Sudan
Chief Scientific Advisor
The chemist who literally wrote the research on HOCl.
Dr. Lori I. Robins is a distinguished chemist, academic leader, and researcher whose work has significantly advanced the understanding and application of hypochlorous acid (HOCl) in antimicrobial science and public health. She serves as Professor of Chemistry and Associate Dean at the University of Washington Bothell.
She earned her B.S. in Biochemistry from Brandeis, her Ph.D. in Bioorganic Chemistry from UC Davis, and refined her expertise in lipid biochemistry as a postdoctoral researcher at Duke. Her lab has secured competitive funding from the NSF and NIH, and she served as Principal Investigator on a NIAID grant exploring HOCl for sanitation and odor control in rural communities.
Since 2015, Dr. Robins' research has focused extensively on active chlorine compounds — examining HOCl's efficacy in inactivating clinically significant pathogens, malodor control, and chronic wound care. She has authored more than 20 peer-reviewed publications and is a co-inventor on two U.S. patent applications for HOCl-based therapeutics.
Ph.D. Bioorganic Chem.
UC Davis · Duke postdoc
Professor & Associate Dean
UW Bothell
20+ HOCl Papers
Peer-reviewed since 2015
NSF / NIH / NIAID
Federally funded research

The Scientist
Dr. Lori I. Robins
Ph.D. · Chief Scientific Advisor

Executive Chairman
Simon Johnston
B.A. · Entrepreneur & Advisor
Executive Chairman
The entrepreneur who turns breakthrough ideas into businesses.
Simon Johnston is a seasoned entrepreneur and innovator with over 35 years of experience across the healthcare and textile industries. As both a business owner and executive, he has consistently transformed breakthrough ideas into commercially successful ventures.
Holding seven U.S. patents — including multiple in polymer chemistry — Simon brings deep expertise in advanced materials, technology licensing, and global business development. His strength lies in guiding early-stage companies from concept to commercialization, building scalable strategies, and forging high-value B2B partnerships.
A decorated combat veteran, Simon served in the U.S. Army from 1966–1968. He holds a Bachelor of Arts degree from the University of Washington (with Honors).
Simon's career reflects a proven ability to turn innovation into sustainable, growth-driven businesses — making him a key force behind Medesol Global's mission to deliver next-generation solutions grounded in science.
7 U.S. Patents
Polymer chemistry & materials
35+ Years
Healthcare & textile industries
Combat Veteran
U.S. Army · 1966–1968
B.A.
University of Washington (with Honors)
Chief Revenue Officer & Equity Partner
The leader who turns growth into market success.
Jim G. Jacobs is a healthcare industry veteran with more than 30 years of experience driving growth, building high-performing teams, and commercializing innovative products across the medical, dental, and healthcare markets.
Throughout his career, Jim has held executive leadership positions with some of the industry's most respected organizations, leading national and global sales teams, developing strategic partnerships, and delivering significant revenue growth. His expertise spans healthcare distribution, infection prevention, OEM and private-label partnerships, and go-to-market strategies across complex healthcare networks.
Jim spent seven years with Danaher, a global leader in healthcare and life sciences, where he was a member of the team that helped launch CaviCide® and CaviWipes® into the medical and dental markets. These products went on to become category-leading brands and remain among the most trusted infection prevention solutions in healthcare today.
As Chief Revenue Officer and Equity Partner of OdorSol, Jim leads the company's commercial strategy, strategic partnerships, retail expansion, and business development initiatives. Working alongside the company's scientific leadership team, he is focused on bringing innovative, science-driven hypochlorous acid (HOCl) solutions to consumers, businesses, and healthcare markets through operational excellence and customer-focused execution.
Jim's passion for innovation, combined with decades of leadership experience and a proven track record of building successful organizations, helps position OdorSol for long-term growth as the company expands its portfolio of safe, effective, and environmentally responsible products.
30+ Years
Healthcare leadership & growth
CRO & Equity Partner
Commercial strategy & expansion
CaviCide / CaviWipes
Category-leading brand launches
Infection Prevention
Medical & dental markets

Chief Revenue Officer
Jim G. Jacobs
Equity Partner
100% science. Zero compromise.
Most cleaning brands are built by marketers. OdorSol was invented by a veterinarian, formulated by microbiologists, and validated by a chemist whose entire career is HOCl research. That's why we can stand behind every claim — and every bottle.
